MENIN inhibitors are a promising class of targeted oncology drugs in development for acute leukemias and certain solid tumors, but their use is often limited by severe dermatological side effects.
NEW YORK — Because of their heterogeneity in appearance, drug-induced skin rashes are a common diagnostic challenge, but eruptions in skin of color, particularly those with a delayed onset, require a ...
Hosted on MSN
Topical treatment offers relief from painful skin rash caused by targeted cancer therapy
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...
Chemo rash is one of the most common side effects of cancer treatment. These rashes usually aren’t serious, but they can cause pain, itching, and other uncomfortable symptoms. Chemotherapy, also ...
Nearly every medication comes with side effects, and in cancer therapies, they can be severe. Clinicians must often weigh the benefits of treatment against potential adverse effects. At the 29th ...
Please provide your email address to receive an email when new articles are posted on . ATR-04 is currently being developed to treat dermal toxicity from epidermal growth factor receptor inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results